ISRG Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Declines

Core Insights - Intuitive Surgical (ISRG) reported strong fourth-quarter 2025 results, with adjusted earnings per share (EPS) of $2.53, exceeding estimates by 12.4% and showing a year-over-year improvement of 14.5% [1][9] - The company achieved revenues of $2.87 billion, reflecting a 19.1% year-over-year increase, driven by higher da Vinci system placements and increased procedure volumes [2][9] - The stock rose 2.4% in after-hours trading following the earnings report, indicating positive market reception [10] Revenue Details - Total revenues reached $2.87 billion, surpassing the Zacks Consensus Estimate by 4.7% [2] - The growth was attributed to an increase in installed systems and da Vinci procedure volume [2] Segmental Performance - Instruments & Accessories: Revenues of $1.66 billion, up 17.5% year over year, driven by a 17% increase in da Vinci procedure volume and significant growth in Ion and SP procedures [3] - Systems: Revenues totaled $785.9 million, a 20.1% increase year over year, supported by higher system placements and average selling prices [4] - Services: Revenues amounted to $422 million, reflecting a 21.5% increase from the previous year [5] Margins and Expenses - Adjusted gross profit was $1.94 billion, with a gross margin of 67.6%, down 210 basis points from the prior year [6][9] - Selling, general, and administrative expenses rose to $687.1 million, up 12.2% year over year, while research and development expenses increased by 19.7% to $352.9 million [6] Financial Position - The company ended the fourth quarter with cash, cash equivalents, and investments totaling $9.03 billion, an increase from $8.43 billion in the previous quarter [8] Procedure Volume and Utilization - Global da Vinci procedure volume increased approximately 18% in 2025, with U.S. procedures up 15% and international procedures rising 23% [13] - Average da Vinci utilization increased by 4% globally in the fourth quarter, reflecting improved efficiency from dV5 adoption [14] Future Guidance - Intuitive Surgical projects da Vinci procedure growth of 13%–15% for 2026, with stable gross margins expected in the 67%–68% range [15] - The company plans to invest in early-stage R&D and digital capabilities, anticipating operating expenses to grow by 11%–15% [15][16]